Oxford Immunotec Financing – Series B Closed
Oxford Immunotec, the T cell diagnostics company, announced today that it has closed a £7M series B private equity financing.
We publish news of technology innovations, investment opportunities, together with updates from spinout & startup companies and licensees
Oxford Immunotec, the T cell diagnostics company, announced today that it has closed a £7M series B private equity financing.
Devices Enable 24-hour Monitoring of Non-Powered Assets, Increased Asset Utilization and Efficiency, Visible Asset Management, Improved Security, and Minimized Theft/Damage/Loss for up to 3 years
A new spin-out from Oxford University, Spinox, is aiming to devise novel ways to copy spiders' ability to spin silks. The new silks may be used for sutures or woven material for surgical implants, protective clothing and in sports equipment.
Oxitec Ltd is pleased to announce that it is a member of a consortium that has been offered funding to develop new genetic strategies for control of dengue virus.
Oxitec Limited announces the completion of its second funding round of £1.3m, led by Oxford Capital Partners. The existing investors, East Hill Advisors, LLC from Boston and the University of Oxford (through the Isis College Fund), have made further investments in the company as part of this round. Oxford Capital Partners invested £550,000.
BioAnalab Limited, the Oxford-based specialist contract analytical laboratory, today announced the successful completion of a further round of private equity funding totalling £440,000. The round was led by Octopus Asset Management, who invested £250,000 through the BioScience Venture Capital Trust.
IP2IPO Group plc (AIM: IPO) ("IP2IPO"), the intellectual property company that specialises in commercialising university technology, is pleased to announce that it has acquired a stake of 44.3% in Oxford NanoLabs Limited ("ONL"), a spin-out company from the Chemistry Department at the University of Oxford.
The technology transfer operations of the two Universities in Oxford have formed a partnership which provides Oxford Brookes University staff with access to the resources of Oxford University Innovation, the technology transfer company of the University of Oxford. This will help with commercialising new ideas from Oxford Brookes’ research and encourage Oxford Brookes staff to exploit their ideas through access to the networks and expertise available from Oxford University Innovation.
Dr Tiancun Xiao of Oxford’s Inorganic Chemistry Laboratory has received a 2005 Innovation Award from the Carbon Trust for his work turning methane from waste materials into hydrogen which can be used in fuel cells.
BioAnaLab Limited, a specialist contract analytical laboratory, has recently published its annual accounts for 2003-2004.